期刊
JOURNAL OF ORGANOMETALLIC CHEMISTRY
卷 902, 期 -, 页码 -出版社
ELSEVIER SCIENCE SA
DOI: 10.1016/j.jorganchem.2019.120966
关键词
Ruthenium; Arene ligand; Picolinic acid; Antitumor activity
资金
- Ministry of Education, Science and Technological Development of the Republic of Serbia [172035, 41026]
Four mono- (1-4) and four binuclear Ru(II) arene (5-8) complexes have been isolated from the reaction of [Ru(eta(6)-benzene)Cl(mu-Cl)](2) or [Ru(eta(6)-toluene)Cl(mu-Cl)](2) with 2-pyridinecarboxylic acid and 6-fluoro-2-pyridinecarboxylic acid. Their structural characterization included IR and NMR spectroscopy and MS spectrometry. The cytotoxic potential of the compounds has been tested by MTT assay in seven human cancer cell lines: alveolar basal adenocarcinoma (A549), large cell lung carcinoma (HTB177), colorectal carcinoma (HCT116), malignant melanoma (A375), prostate adenocarcinoma (PC3), breast carcinoma (MDA-MB-453), cervix adenocarcinoma (HeLa), and one human non-malignant lung fibroblast cell line (MRC-5). Mononuclear complexes 1 and 3 carrying 2-pyridinecarboxylic acid have displayed moderate antiproliferative effect toward HCT116 and HeLa, slightly better in comparison to their binuclear analogues, 5 and 7. The highest activity and cytoselectivity has been observed 1 as it has reduced viability of HCT116 cells 1.5 times more efficiently (IC50 = 27.5 mu M), than of the MRC-5 cells (IC50 = 41.3 mu M). In contrast to 1 and 3, compounds 2, 4-8 have been found to exhibit lack of cytotoxicity or mild cytotoxicity with IC50 values ranging from 100 to 300 mu M. (C) 2019 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据